|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gayatri Khanvilkar, MPharm, Ajit Bhagat, and Tejas Gunjikar, PhD, investigate bulking agents and disintegrants to develop efficacious Rotonavir tablets with improved in vitro release.
|
|
|
Dr. Stephen Rumbelow, Life Sciences Research Fellow for Croda Inc., discusses polysorbates, a key excipient used for stabilizing drug molecules in injectable dosage forms.
|
|
|
Masumi Dave, PhD, and Rollie Fuller monitor in this study ASA hydrolysis in different formulations using UPLC and TAM with the objective of comparing these methods for agreement, speed, and efficiency in predicting drug stability. In parallel, they assess the impact of the excipient choices on the stability of ASA.
|
|
|
Jim Huang, PhD, reviews how a pediatric formulation should consider the following factors: difference in physiological and pharmacokinetic of patient populations, dosage form selection, route of administration, dose accuracy, dose flexibility, drug and excipient tolerability (safety and toxicity), patient compliance (palatability/swallowability), stability, and drug accessibility.
|
|
|
|
|
|
|
|
|

Proveris Scientific is an instrument and laboratory service company that creates today’s most advanced testing solutions for orally inhaled and nasal drug product (OINDP) drug development and manufacturing. As partners to our clients we, accelerate successful product development, and prevent late-stage development failures, realize significant savings in time and resources by streamlining testing workflows, evaluate the suitability of various OINDP delivery devices and optimize device parameters for maximum efficacy, and optimize testing variables to maintain batch-to-batch reproducibility, simplifying regulatory submissions. Click here for more.


For over 30 years, DDL has provided extraordinary service and specialized testing expertise to the medical device and pharmaceutical industries. Our reliable quality, responsive attention, and on-schedule completion for packaging, medical device, and combination products testing secures confidence in performance and safety while achieving regulatory compliance. DDL’s package testing services evaluate the strength and integrity of packaging systems before and after simulating the anticipated distribution and storage conditions that the systems may undergo. Packaging professionals use this combination of simulation and evaluation to validate package compliance with ASTM, ISO, ISTA and other accepted industry standards. DDL offers full service package testing in Eden Prairie, MN and Irvine, CA, and select package testing capabilities in Edison, NJ. Click here for more.
|
|
|
|
|
|
 |
|
Ocugen, Inc. recently announced the first patient has been dosed in the Phase 1/2 clinical trial of OCU400, a modifier gene therapy candidate for the treatment of retinitis pigmentosa….
|
|
 |
|
Silo Pharma, Inc. recently announced it has entered into an agreement with Frontage Laboratories, a CRO providing integrated, science-driven, product development services throughout the….
|
|
 |
|
Vyant Bio, Inc. and OrganoTherapeutics recently announced they have entered into a collaboration agreement to work toward accelerating the discovery of drugs for the treatment of….
|
|
 |
|
Mapi Pharma Ltd. recently announced it has been granted US Patent No. 11,167,003 titled Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis….
|
|
 |
|
eTheRNA Manufacturing recently introduced a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and early preclinical development of RNA-based….
|
|
 |
|
Owen Mumford Pharmaceutical Services recently announces its alliance with Noble International, an Aptar Pharma company and world leader in providing drug delivery….
|
|
|
|
|
|
|
|
 |
|
Antibody Drug Conjugates (ADCs) have a highly specific mechanism of action which is an advantage for the treatment of several oncology indications…..
|
|
 |
|
Celanese and ThermoFisher Scientific have partnered together to present the value of the VitalDose® EVA drug delivery platform and manufacturing through Hot Melt Extrusion (HME) on September 9, 2021.
|
|
 |
|
The need for flexible solutions for potent product handling is increasing. We’ll discuss the proven benefits of aseptic isolator systems in sterile environments and take a look at real feedback from real customers of ours in an upcoming webinar on Tuesday, November 16th at 11:00 AM EST.
|
|
|
|
|
|
|
|
 |
|
Are you prepared for the HFA phasedown? With many industries switching to more environmentally friendly propellants, pMDI developers need to be ready. Recipharm explore alternative technologies to HFA propellants, and how the devices and formulations can be optimized to ensure …
|
|
 |
|
What techniques should manufacturers employ when working with low-dose drug products?
By: Thomas Daggs, MBA, Vice President, Product Development & Quality Control, and Angelo Consalvo, Director of Manufacturing, Enteris BioPharma
Anyone who takes an oral tablet medication – whether prescribed …
|
|
 |
|
Antibody production is a multi-step complex process and generating reproducible antibodies is highly critical for immunoassays-based research, immunodiagnostics, and immunotherapy. Antibodies’ reproducibility is driven by their specificity and several other factors ranging from antibody design to target validation. Our Antibody …
|
|
|
|
|
Upcoming eNewsletter Features:
April 13 – Prefilled Syringes
April 20 – Inhalation Delivery
|
|
|
|
|
|
|
|